News
-
-
-
-
COMMUNIQUÉ DE PRESSE
MAX Automation SE plans to switch to the General Standard for more efficient capital market communication and a sharper focus on its operating business
MAX Automation SE plans to switch to the General Standard for more efficient capital market communication and operational focus. Reduction of administrative requirements to enhance growth initiatives -
COMMUNIQUÉ DE PRESSE
Total du nombre de droits de vote et du capital / Information relative au nombre total de droits de vote et d'actions composant le capital
31 rue de Monceau - 75008 Paris - Informations sur les droits de vote et d'actions au 30 novembre 2025 conformément au Code de commerce et au Règlement de l'AMF -
COMMUNIQUÉ DE PRESSE
Total number of voting rights and capital / Information on the total number of voting rights and the number of shares making up the capital
Press release on total number of voting rights and shares as of 30 November 2025 under French commercial code and Financial Markets Authority regulations -
-
-
-
COMMUNIQUÉ DE PRESSE
Revelation Biosciences Has Reached A Quorum For Its December 3, 2025 Special Meeting
Revelation Biosciences, Inc. achieves quorum for Special Meeting on December 3, 2025, announces FDA meeting update & financial results. The company focuses on rebalancing inflammation using Gemini
